Or Doing Drugs for Your Heartbeat

Slides:



Advertisements
Similar presentations
Antiarrhythmic Drugs.
Advertisements

Electrophysiology (Conduction System of Heart)
Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Aims Introduction to the heart.
Drugs for Dysrhythmias 19. Learning Outcomes 1. Explain how rhythm abnormalities can affect cardiac function. 2. Illustrate the flow of electrical impulses.
Na+ channel blocker: Na+ channel block depends on: HR
Mechanisms of cardiac arrhythmias
ECG: Electrocardiography Exercise 31
Cardiac Arrhythmias.
ECE 501 Introduction to BME ECE 501 Dr. Hang. Part IV Bioinstrumentation Electrocardiogram ECE 501 Dr. Hang.
Drugs used to treat cardiac arrhythmias
Antiarrhythmic Drugs.
Anti-arrhythmic drugs
Anti arrhythmic Drugs Marwa A. Khairy , MD.
Properties of Cardiac Muscle
Advanced Cardiac Care in the Streets Understanding EKGs Ray Taylor Valencia Community College Electrophysiology.
Section 2 Electrophysiology of the Heart
ANTIARRHYTHMIC DRUGS Department of Pharmacology and Toxicology
© Assoc. Prof. Ivan Lambev
Section 3, Lecture 4 Antiarrhytmic drugs cont…
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 23 Antiarrhythmic Drugs.
Antidysrhythmic Drugs
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antidysrhythmic Drugs.
CARDIOVASCULAR SYSTEM PHYSIOLOGY. Pulmonary circulation: Path of blood from right ventricle through the lungs and back to the heart. Systemic circulation:
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Chapter Goals After studying this chapter, students should be able to describe the general functions of the major components of the heart. 2. describe.
Cardiac electrical activity
The Electrical System of the Heart. Cardiac Muscle Contraction Depolarization of the heart is rhythmic and spontaneous About 1% of cardiac cells have.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. Cardiac arrhythmia Docent.
Lecture Objectives Describe sinus arrhythmias Describe the main pathophysiological causes of cardiac arrhythmias Explain the mechanism of cardiac block.
BIMM118 Cardiac Arrhythmia Arrhythmias : Abnormal rhythms of the heart that cause the heart to pump less effectively Arrhythmia occurs: –when the heart’s.
ECG How ECG is done? The electrical impulses originating from the heart can be transmitted to the body surface because the body contains fluids.
Section 3 Lecture 3 Antiarrhythmic Drugs Heart beats (HB) originate from AV node Normal 70 beats/min at rest Arrhythmia (dysrhythmia): Abnormal.
Electrophysiology (Conduction System of Heart)
Electrical Activity of Heart & ECG
Conductive System of the Heart. Conduction system The specialized heart cells of the cardiac conduction system generate and coordinate the transmission.
Copyright © 2008 Thomson Delmar Learning CHAPTER 12 Electrophysiology of the Heart.
23 Antiarrhythmic Drugs.
Antiarrhythmic Drugs. Drug List Class 1 Sodium Channel Blockers Class 2 Beta-blockers Class 3 Potassium Channel blockers Class 4 Calcium Channel Blockers.
Arrhythmias. Cardiac dysrhythmia Cardiac dysrhythmia (arrhytmia) Abnormal electrical activity in the heart.
ANTI-ARRHYTHMIC DRUGS
Lab 2 The Intrinsic Cardiac Conduction System 1/24/20101Mickey Dufilho.
Cardiac Arrhythmia.
Electrical Activity of the Heart
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings Differences in Contraction Mechanisms  Heart has autorhythmicity (approx. 1%)
Heart Beat and Blood Pressure. Heart Beat Animation ions/ ions/
Pharmacology 4 Dr. Khalil Makki. Antiarrhythmic Drugs.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Antiarrhythmic Drugs.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Disorders of Cardiac Conduction and Rhythm.
Cardiovascular Cardiovascular pharmacology pharmacology.
Opening Assignment – Copy and answer 1. The two chambers on the superior side of the heart are called ________________. 2. The two chambers on the inferior.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Disorders of Cardiac Conduction and Rhythm.
1 Topics to be addressed: Blood Anatomy of Blood Vessels Anatomy of the Heart The Conduction System The Cardiac Cycle Cardiodynamics Blood Flow and its.
Dr Laith M Abbas Al-Huseini
Electrical Properties of the Heart
Heart Function – Cardiac Cycle and the Electrocardiogram (ECG)
Objective 12 Electrocardiograms
Antidysrhythmic Agents
©2012 Lippincott Williams & Wilkins. All rights reserved.
The Cardiac Cycle Heart Murmur
Cardiovascular Physiology
Conduction System of the Heart
Ann Parker Cardiology Pharmacist Frimley Health
CVS Impulse generation
Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
Chapter 30 Antiarrhythmic Drugs
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family.
Drugs used in the treatment of arrhythmia I
Presentation transcript:

Or Doing Drugs for Your Heartbeat Antiarrhythmic Drugs Or Doing Drugs for Your Heartbeat

Background Recall: to function efficiently, heart needs to contract sequentially (atria, then ventricles) and in synchronicity Relaxation must occur between contractions (not true for other types of muscle [exhibit tetany  contract and hold contraction for certain length of time]) Coordination of heartbeat is a result of a complex, coordinated sequence of changes in membrane potentials and electrical discharges in various heart tissues

Arrhythmia Heart condition where disturbances in Pacemaker impulse formation Contraction impulse conduction Combination of the two Results in rate and/or timing of contraction of heart muscle that is insufficient to maintain normal cardiac output (CO) To understand how antiarrhythmic drugs work, need to understand electrophysiology of normal contraction of heart

Normal heartbeat and atrial arrhythmia Normal rhythm Atrial arrhythmia AV septum

Ventricular Arrhythmia Ventricular arrhythmias are common in most people and are usually not a problem but… VA’s are most common cause of sudden death Majority of sudden death occurs in people with neither a previously known heart disease nor history of VA’s Medications which decrease incidence of VA’s do not decrease (and may increase) the risk of sudden death treatment may be worse then the disease!

Electrophysiology - resting potential A transmembrane electrical gradient (potential) is maintained, with the interior of the cell negative with respect to outside the cell Caused by unequal distribution of ions inside vs. outside cell Na+ higher outside than inside cell Ca+ much higher “ “ “ “ K+ higher inside cell than outside Maintenance by ion selective channels, active pumps and exchangers

ECG (EKG) showing wave segments Contraction of ventricles ECG (EKG) showing wave segments Repolarization of ventricles Contraction of atria

Cardiac Action Potential Divided into five phases (0,1,2,3,4) Phase 4 - resting phase (resting membrane potential) Phase cardiac cells remain in until stimulated Associated with diastole portion of heart cycle Addition of current into cardiac muscle (stimulation) causes Phase 0 – opening of fast Na channels and rapid depolarization Drives Na+ into cell (inward current), changing membrane potential Transient outward current due to movement of Cl- and K+ Phase 1 – initial rapid repolarization Closure of the fast Na+ channels Phase 0 and 1 together correspond to the R and S waves of the ECG

Cardiac Na+ channels

Cardiac Action Potential (con’t) Phase 2 - plateau phase sustained by the balance between the inward movement of Ca+ and outward movement of K + Has a long duration compared to other nerve and muscle tissue Normally blocks any premature stimulator signals (other muscle tissue can accept additional stimulation and increase contractility in a summation effect) Corresponds to ST segment of the ECG. Phase 3 – repolarization K+ channels remain open, Allows K+ to build up outside the cell, causing the cell to repolarize K + channels finally close when membrane potential reaches certain level Corresponds to T wave on the ECG

Differences between nonpacemaker and pacemaker cell action potentials PCs - Slow, continuous depolarization during rest Continuously moves potential towards threshold for a new action potential (called a phase 4 depolarization)

Mechanisms of Cardiac Arrhythmias Result from disorders of impulse formation, conduction, or both Causes of arrhythmias Cardiac ischemia Excessive discharge or sensitivity to autonomic transmitters Exposure to toxic substances Unknown etiology

Disorders of impulse formation No signal from the pacemaker site Development of an ectopic pacemaker May arise from conduction cells (most are capable of spontaneous activity) Usually under control of SA node  if it slows down too much conduction cells could become dominant Often a result of other injury (ischemia, hypoxia) Development of oscillatory afterdepolariztions Can initiate spontaneous activity in nonpacemaker tissue May be result of drugs (digitalis, norepinephrine) used to treat other cardiopathologies

Afterdepolarizations

Disorders of impulse conduction May result in Bradycardia (if have AV block) Tachycardia (if reentrant circuit occurs) Reentrant circuit

Antiarrhythmic drugs Biggest problem – antiarrhythmics can cause arrhythmia! Example: Treatment of a non-life threatening tachycardia may cause fatal ventricular arrhythmia Must be vigilant in determining dosing, blood levels, and in follow-up when prescribing antiarrhythmics

Therapeutic overview Na+ channel blockade β-adrenergic receptor blockade Prolong repolarization Ca2+ channel blockade Adenosine Digitalis glycosides

Classification of antiarrhythmics (based on mechanisms of action) Class I – blocker’s of fast Na+ channels Subclass IA Cause moderate Phase 0 depression Prolong repolarization Increased duration of action potential Includes Quinidine – 1st antiarrhythmic used, treat both atrial and ventricular arrhythmias, increases refractory period Procainamide - increases refractory period but side effects Disopyramide – extended duration of action, used only for treating ventricular arrthymias

Classification of antiarrhythmics (based on mechanisms of action) Subclass IB Weak Phase 0 depression Shortened depolarization Decreased action potential duration Includes Lidocane (also acts as local anesthetic) – blocks Na+ channels mostly in ventricular cells, also good for digitalis-associated arrhythmias Mexiletine - oral lidocaine derivative, similar activity Phenytoin – anticonvulsant that also works as antiarrhythmic similar to lidocane

Classification of antiarrhythmics (based on mechanisms of action) Subclass IC Strong Phase 0 depression No effect of depolarization No effect on action potential duration Includes Flecainide (initially developed as a local anesthetic) Slows conduction in all parts of heart, Also inhibits abnormal automaticity Propafenone Also slows conduction Weak β – blocker Also some Ca2+ channel blockade

Classification of antiarrhythmics (based on mechanisms of action) Class II – β–adrenergic blockers Based on two major actions 1) blockade of myocardial β–adrenergic receptors 2) Direct membrane-stabilizing effects related to Na+ channel blockade Includes Propranolol causes both myocardial β–adrenergic blockade and membrane-stabilizing effects Slows SA node and ectopic pacemaking Can block arrhythmias induced by exercise or apprehension Other β–adrenergic blockers have similar therapeutic effect Metoprolol Nadolol Atenolol Acebutolol Pindolol Stalol Timolol Esmolol

Classification of antiarrhythmics (based on mechanisms of action) Class III – K+ channel blockers Developed because some patients negatively sensitive to Na channel blockers (they died!) Cause delay in repolarization and prolonged refractory period Includes Amiodarone – prolongs action potential by delaying K+ efflux but many other effects characteristic of other classes Ibutilide – slows inward movement of Na+ in addition to delaying K + influx. Bretylium – first developed to treat hypertension but found to also suppress ventricular fibrillation associated with myocardial infarction Dofetilide - prolongs action potential by delaying K+ efflux with no other effects

Classification of antiarrhythmics (based on mechanisms of action) Class IV – Ca2+ channel blockers slow rate of AV-conduction in patients with atrial fibrillation Includes Verapamil – blocks Na+ channels in addition to Ca2+; also slows SA node in tachycardia Diltiazem

Pacemakers Surgical implantation of electrical leads attached to a pulse generator Over 175,000 implanted per year Leads are inserted via subclavicle vein and advanced to the chambers on the vena cava (right) side of the heart Two leads used, one for right atrium, other for right ventricle Pulse generator containing microcircuitry and battery are attached to leads and placed into a “pocket” under the skin near the clavicle Pulse generator sends signal down leads in programmed sequence to contract atria, then ventricles Pulse generator can sense electrical activity generated by the heart and only deliver electrical impulses when needed. Pacemakers can only speed up a heart experiencing bradycardia, they cannot alter a condition of tachycardia

Implantation of Pacemaker